88IV - Public company info - CanSino Biologics Inc.

Input the stock code or the company name

CanSino Biologics Inc. - H Shares, 06185.HK - Cash Flow	2019-12	2018-12	2017-12	2016-12
Net Cash Flow from Operating Activities	-173,718	-123,843	-56,529	-34,533
Net Cash Flow from Return on Investments & Servicing of Finance	-5,254	-7,388	-4,404	-186
Interest Received	3,529	205	228	150
Interest Paid	-8,783	-7,593	-4,632	-336
Dividend Received	0	0	0	0
Dividend Paid	0	0	0	0
Others	0	0	0	0
Taxes (Paid) / Refunded	0	0	0	0
Net Cash Flow from Investing Activities	-797,770	117,625	-461,490	-173,543
Additions to Fixed Assets	-110,045	-149,423	-164,469	-126,080
Disposal of Fixed Assets	10	230	0	0
Increase in Investments	-461,000	-1,448,200	-2,081,650	-251,000
Decrease in Investments	503,155	1,724,529	1,784,137	188,667
Net Cash Flow with Related Parties	0	0	0	81,822
Others	-729,890	-9,511	492	-66,952
Net Cash Flow before Financing Activities	-976,742	-13,606	-522,423	-208,262
Net Cash Flow from Financing Activities	1,099,609	52,648	489,004	151,151
New Loans	0	41,667	39,004	69,329
Loans Repayment	-7,302	0	0	0
Fixed Income/Debt Instruments	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0
Equity Financing	1,127,770	17,486	450,000	0
Net Cash Flow with Related Parties	0	0	0	81,822
Others	-20,859	-6,505	0	0
Increase(Decrease) in Cash & Cash Equivalents	122,867	39,042	-33,419	-57,111
Cash & Cash Equivalents at Beginning of Year	57,381	18,247	52,548	106,974
Net Cash Flow due to Change in Exchange Rate/Others	21,725	92	-882	2,685
Cash & Cash Equivalents at End of Year	201,973	57,381	18,247	52,548
Currency	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	0	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - CanSino Biologics Inc. - H Shares , 06185.HK